Cationic beta-lactoglobulin nanoparticles have been developed as novel nutraceutical/drug carriers.
Satisfactory results were observed in simulated physiological processes ranging from digestion to cellular uptake.
Surface properties and sizes of the nanocarriers determined their performances in different biological processes.